Table 8 Overview of high-quality studies reporting relative statistical significance (representatives)
Category & domain (n=)* | Statistical significance** | |||||
|---|---|---|---|---|---|---|
P < 0.10 | P < 0.05 | P < 0.01 | P < 0.001 | Total | Not significant | |
Outcome | ||||||
 Protection duration (n = 4) | 0 | 1 | 2 | 1 | 4 | 1 |
 Vaccine effectiveness (n = 6) | 0 | 3 | 3 | 1 | 7 | 0 |
 Vaccine risk (n = 5) | 1 | 4 | 0 | 0 | 5 | 0 |
Process | ||||||
 Dosing & visits (n = 2) | 0 | 1 | 1 | 0 | 2 | 0 |
 Service delivery (n = 2) | 0 | 1 | 0 | 0 | 1 | 2 |
 Target group (n = 1) | 0 | 0 | 1 | 0 | 1 | 0 |
 Time (n = 1) | 0 | 0 | 1 | 0 | 1 | 0 |
 Vaccination age (n = 1) | 0 | 1 | 0 | 0 | 1 | 0 |
 Vaccine accessibility (n = 1) | 0 | 1 | 0 | 0 | 1 | 0 |
Cost | ||||||
 Cost (n = 5) | 0 | 1 | 4 | 1 | 6 | 0 |
Other | ||||||
 Context (n = 1) | 0 | 2 | 0 | 0 | 2 | 0 |
 Disease risk (n = 1) | 0 | 1 | 0 | 0 | 1 | 0 |
 Information (n = 1) | 0 | 0 | 1 | 0 | 1 | 1 |